ALLR · Allarity Therapeutics
AI read · Good for ALLR
The AI's read
This gives stenoparib more patient groups to be tested in and may widen its development path. Earlier results were described as showing lasting benefits and improved survival. No results from the added groups are reported, so the promise still depends on testing.